This study tests a new medicine called GNR-127 for people with seasonal allergies to birch pollen. It involves 150 adults aged 18-55 who have had birch pollen allergies for at least 2 years. The goal is to find a safe and effective dose that reduces symptoms like sneezing, runny …
Phase: PHASE1, PHASE2 • Sponsor: AO GENERIUM • Aim: Symptom relief
Last updated May 04, 2026 02:17 UTC